0.2643USD+0.38%Mkt Cap: 105.48M $P/E: —Today
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segme…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$43.41BUSDP/E 20.1
$29.89BUSDP/E 12.7
$22.70BUSDP/E 19.0
$18.66BUSD
$15.34BUSDP/E 117.3
$15.81BUSDP/E 22.8
$14.67BUSDP/E 26.4
$12.24BUSD
$8.57BUSDP/E 18.8
$7.25BUSD
$6.74BUSDP/E 53.8
$6.56BUSDP/E 24.0
$6.23BUSDP/E 37.3
$4.61BUSDP/E 14.0
$4.01BUSDP/E 20.9
$4.30BUSD
$3.69BUSDP/E 12.7
$3.32BUSDP/E 16.5
$2.82BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
 BGM Group Ltd. (BGM) Surges 35% as AI, Biopharma Transformation Gains Investor Attention We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. BGM Group Ltd. is one of them. BGM Group Ltd. (NASDAQ:BGM), a China-based pharmaceutical and chemical company, is rapidly transforming into an AI- and biopharma-focused enterprise. Through subsidiaries, the company develops specialty and generic drugs while expanding into intelligent robotics […] | IInsider Monkey | |